The Drug Information Association' was founded in New York City, June 18, 1965. The DIA is an independent society designed to further modem technology of communication in medical, pharmaceutical and allied fields. It is (I) a medium for free expression of ideas of individuals from all professional, industrial, govemmental, and related groups concerned with drug information; (2) a medium for mutual instruction in the technology of drug information processing in all its ramifications collecting, selecting, abstracting, indexing, coding, vocabulary building, terminology standardizing, computerizing data storage and retrieval, tabulating, correlating, computing, evaluating, writing, editing, reporting, and publishing; and (3) a medium for reciprocal interchange of know-how about drug information handling. To attain its objectives, DIA has chosen the projectoriented approach. There are many long-standing drug information problems which remain unresolved year after year because mountains of data are increasing so rapidly it is impossible to process them completely and accurately. Typical projects include: (I) a master summary for the animal, patient, and other data deemed essential for proving that a drug is sufficiently safe and efficacious for marketing; (2) case report forms standardized as much as is practicable for each drug category; and (3) an intemationally acceptable standard terminology for all known drugs and all known diseases. One project which DIA could undertake immediately is publication of the Adverse Drug Reaction Dictionary, now used by the Food and Drug Administration, which could then be made readily available at relatively low cost to all who handle adverse drug reaction information. The intense interest generated by DIA can only be of permanent value if the Association can sponsor meetings at a high intellectual level and undertake and complete one useful project after another. The possibilities for worthwhile projects are virtually unlimited. It does not wish, does not intend to work on projects now being adequately covered by other groups, unless of course invited to participate. The DIA is designed to function informally, strictly as a professional, individual membership organization. Its mission in the drug information field is to help find solutions for knotty problems, to act as a sounding board for new ideas, and to promote harmonious and productive interactions among all who w6rk with drug data.